Imvaq Therapeutics

Imvaq Therapeutics is an innovative cancer immunotherapy company founded by world-leading researchers from Memorial Sloan Kettering Cancer Center. The company is developing novel armed immunostimulatory therapies based on viruses to treat various metastatic solid tumors, including skin cancer, sarcoma, and difficult-to-treat tumors such as triple-negative breast cancer.